Showing results (601-610 of 632) with videos related to
Sort By:
Pageof 64
Cancer Research|April 28, 2018
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer ProgressionYi-Zi Zheng, Meng-Zhu Xue, Hong-Jie Shen, et al.Journal of Medicinal Chemistry|November 16, 2010
Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonistsBingwei V Yang, David S Weinstein, Lidia M Doweyko, et al.Nature Biotechnology|November 20, 2003
An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteriaXiao-Qing Qiu, He Wang, Xiao-Fong Lu, et al.Cell Reports|April 20, 2025
KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathwayJia-Ming Wang, Feng-Hao Zhang, Hai-Yun Xie, et al.Inflammatory Bowel Diseases|March 5, 2015
Factors associated with mucosal healing in patients with ulcerative colitis in clinical remissionHai Yun Shi, Francis K L Chan, Steven W C Tsang, et al.Heart Rhythm|July 17, 2018
Supraventricular tachycardias, conduction disease, and cardiomyopathy in 3 families with the same rare variant in TNNI3K (p.Glu768Lys)Svitlana Podliesna, Julian Delanne, Lindsey Miller, et al.Bioorganic & Medicinal Chemistry Letters|August 20, 2013
Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonistsJames E Sheppeck, John L Gilmore, Hai-Yun Xiao, et al.Journal of Medicinal Chemistry|April 24, 2015
Improving the pharmacokinetic and CYP inhibition profiles of azaxanthene-based glucocorticoid receptor modulators-identification of (S)-5-(2-(9-fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide (BMS-341)Michael G Yang, T G Murali Dhar, Zili Xiao, et al.Nature Metabolism|September 19, 2025
Mapping the plasma metabolome to human health and disease in 274,241 adultsJia You, Xi-Han Cui, Yi-Lin Chen, et al.Bioorganic & Medicinal Chemistry Letters|June 30, 2010
Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonistsHai-Yun Xiao, Aaron Balog, Ricardo M Attar, et al.Pageof 64